WilliamWerbelMDPhD

HIV/AIDS Medicine, Transplant/Immunocompromised States, Microbiology

Physician

Dr. Werbel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4940 Eastern Avenue
Baltimore, MD 21224
Phone+1 410-550-9080

Fax+1 410-550-1169

University of Michigan Medical SchoolClass of 2013
McGaw Medical Center of Northwestern UniversityChief Residency, Internal Medicine

PubMed

A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching.
Jenny M Lee, Jaiprasath Sachithanandham, John S Lee, Janna R Shapiro, Maggie Li
Microbiology Spectrum. 2025-01-31
Impact of Bebtelovimab Treatment Timing on COVID-19 Outcomes in Ambulatory Solid Organ Transplant Recipients.
Sonsoles Salto-Alejandre, Willa Cochran, Zishan Siddiqui, Julie Langlee, Lauren Boyer
Transplant Infectious Disease. 2024-11-16
2 citations
Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases.
Mayan S Teles, Janetta Brundage, Teresa Po-Yu Chiang, Jennifer L Alejo, Nicolas Henriquez
The Journal of Rheumatology. 2024-09-01

Study: RSV Vaccine May Be More Effective at Protecting Healthier Older AdultsJanuary 2nd, 2025
Seniors on Immunosuppressant Show Weaker Vaccine ResponsesDecember 31st, 2024
HMN 2024: How Immunocompromised May Not Produce Enough Protective Antibodies Against RSV After VaccinationDecember 31st, 2024
Join now to see all